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(H7N9) virusThe ﬁrst 3 cases of infection with a novel avian-origin
reassortant inﬂuenza A (H7N9) virus were identiﬁed in China
between February and March 2013. The cases were character-
ized by rapidly progressive pneumonia, respiratory failure,
and acute respiratory distress syndrome leading to fatal
outcome. Up till April 30, 2013, a total of 128 cases of H7N9
infection in human have been conﬁrmed, including 24
deaths. However, the accurate mortality rate remains
unknown because many cases might be asymptomatic or
exhibit mild symptoms and therefore go undetected.
Although poultry seems to be the animal reservoir of the
H7N9 virus, the transmission route to humans remains
unclear because approximately 40% of patients were not in
contact with poultry just before they were infected. Notably,
the genetic changes in H7N9 viruses suggest that they are
most capable of human adaptation than all other types of
avian ﬂu viruses, and further adaptations can be expected
even without sustained human-to-human transmission,
except during possible blood-related transmission in two
family clusters.
The poor outcome observed in the ﬁrst 3 cases may be
attributed to delayed treatment with antivirals; oseltamivir
was administered only on day 7 or 8 of illness. Moreover the
2009 Japanese H1N1 pandemic has led us to infer that earlytreatment interventions (o48 h) with neuraminidase inhibi-
tors treatment should be initiated for patients with suspected
or conﬁrmed H7N9 virus infection.
Diagnostic tests and potential H7N9 vaccines should be
rapidly developed for individuals of all ages worldwide who
probably have had no protective immunity as further spread
of infection is possible.
In the past issue of Respiratory Investigation, you can ﬁnd
an original manuscript relating to the clinical management
for severe pneumonia with highly pathogenic avian inﬂuenza
A (H5N1) virus (Respiratory Investigation 50; 140–150, 2012).
Respiratory Investigation welcomes to focus on the topics of
pulmonary medicine in Asia relating to the avian inﬂuenza
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